Association between polypharmacy and health-related quality of life among cancer survivors in the United States
- 24 Downloads
Polypharmacy (PP) is present in many cancer survivors and may lead to lower health-related quality of life (HRQoL). The study’s objective was to evaluate the association between PP and HRQoL among cancer survivors in the US.
A cross-sectional analysis of the Medical Expenditure Panel Survey (MEPS) was conducted. Our analytic sample included all adult patients with cancer, during even years 2008–2014. PP was defined as reported use of five or more unique therapeutic classes of prescription medications. The MEPS measured HRQoL using the Short Form 12-Item Health Survey Version 2 (SF-12v2) physical component summary (PCS) and mental component summary (MCS) scores. Ordinary least squares regressions were used to assess associations between PP and HRQoL controlling for demographic, socioeconomic, and clinical factors.
PP was prevalent among 44.4% of 10.1 million cancer survivors per calendar year (on average) for years 2008, 2010, 2012, and 2014. The mean adjusted PCS score for cancer survivors with PP was 35.8 points, which was significantly lower compared with cancer survivors without PP (39.5) by 3.7 points (p value < .0001). Conversely, the mean adjusted MCS scores were not significantly lower in cancer survivors with PP compared with cancer survivors without PP (44.9 versus 45.4, p value = 0.3145).
PP was prevalent in 44.4% of cancer survivors and was associated with significantly poorer physical HRQoL than reported in their counterparts without PP.
Implications for Cancer Survivors
PP should be examined closely among cancer survivors because of increased association with poorer physical HRQoL.
KeywordsPolypharmacy Cancer survivors Health-related quality of life Medical Expenditure Panel Survey
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors. This manuscript comports with the University of Rhode Island’s Institutional Review Board as exempt status from human subjects research.
- 1.NCI Dictionary of Cancer Terms was originally produced by the National Cancer Institute. Available Online: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship. Accessed May 31, 2019
- 2.Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2012;21(11):2108–17. https://doi.org/10.1158/1055-9965.EPI-12-0740.CrossRefGoogle Scholar
- 3.Cancer treatment & survivorship facts & figures 2016–2017 is accompanied by “Cancer Treatment and Survivorship Statistics, 2016,” a scientific paper published in the American Cancer Society Journal, CA: A Cancer Journal for Clinicians.Google Scholar
- 13.National Cancer Institute (NCI). Late effects of treatment for childhood cancer (PDQ®)–patient version was originally published by the National Cancer Institute. Available Online: https://www.cancer.gov/types/childhood-cancers/late-effects-pdq. Accessed May 31, 2019.
- 17.Medical expenditure panel survey; agency for healthcare research and quality. available: https://meps.ahrq.gov/mepsweb/. Accessed May 31, 2019
- 18.Agency for healthcare research and quality. Medical expenditure panel survey, HC-138: 2010 Full Year Consolidated Data File; 2012. https://meps.ahrq.gov/data_stats/download_data/pufs/h138/h138doc.pdf. Accessed May 31, 2019.
- 19.Machlin S, Soni A, Fang Z. Understanding and analyzing MEPS household component medical condition data. Available Online: https://meps.ahrq.gov/survey_comp/MEPS_condition_data.shtml. Accessed May 31, 2019.
- 26.Agency for healthcare research and quality. Medical expenditure panel survey, HC-135A: 2010 Prescribed Medicines; 2012. https://meps.ahrq.gov/data_stats/download_data/pufs/h135a/h135adoc.pdf. Accessed May 31, 2019.
- 29.Smith C, Kosten S. Multiple imputation: a statistical programming story. PharmaSUG 2017 Paper SP01. Available Online: https://pharmasug.org/proceedings/2017/SP/PharmaSUG-2017-SP01.pdf. Accessed May 31, 2019.
- 30.MEPS Topics: Medical conditions file. Medical Expenditure Panel Survey; Agency for Healthcare Research and Quality. Available: https://meps.ahrq.gov/mepsweb/data_stats/MEPS_topics.jsp?topicid=32Z-1. Accessed May 31, 2019.
- 39.Ware J Jr, Gandek B, Sinclair SJ, et al. Measuring and improving health outcomes: an SF-36 primer for the Medicare health outcomes survey. Health assessment lab and QualityMetric incorporated, Waltham; 2004.Google Scholar
- 40.LeMasters T, Madhavan S, Sambamoorthi U, Kurian S. A population-based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender. Psychooncology. 2013;22(10):2270–82. https://doi.org/10.1002/pon.3288.CrossRefPubMedPubMedCentralGoogle Scholar